Bod completes first order of medicinal cannabis oil • Bod...

Bod completes first order of medicinal cannabis oil

• Bod receives final approval for first import of medicinal cannabis oil

•ODC permission granted for import of Linnea’s proprietary ECs315, 5% CBD in MCT oil – expected in country shortly

• Oil being sourced from major Swiss counterparty, Linnea SA (owned by Schwabe Group and Ispen market capitalisation €10B) • Oil to be made available to patients under TGA’s Special Access Scheme Category B

• Product to also be utilised as a treatment arm in upcoming Phase I Clinical trial – set to commence near term

• Phytocomplex extract provides Bod with numerous revenue, R&D and potential export opportunities

• Oil to be a line extension of Company’s proprietary, patent protected sublingual wafer - expanding Bod’s market opportunity in the global medicinal cannabis sector

Another good update, well done management!